Mayinglong released its 2026 half-year report, with first-half net profit attributable to the parent at 363 million yuan, up 5.6% year on year. Operating revenue was 2.01 billion yuan, up 3.2% year on year. Net profit attributable to the parent after deducting non-recurring items was 342 million yuan, up 6.4% year on year. Net operating cash flow was 430 million yuan, up 38.5% year on year. Second-quarter net profit attributable to the parent was 150 million yuan, up 7.4% year on year. The company continued to focus on anorectal health, eye beauty and skin health, with sales of sanitary wet wipes growing more than 100% year on year.
Mayinglong Pharmaceutical Group Co LtdFirst-half net profit up 5.6% and revenue up 3.2%, with strong cash flow growth.
